Vestand, Formerly Yoshiharu, Delisted from Nasdaq

Nasdaq delisted Vestand Inc., formerly Yoshiharu Ramen, on July 27, according to a July 28 regulatory filing. The company’s shares fell to about $0.02 on Monday and it began trading on the OTC Pink Limited Market. Nasdaq cited prolonged disclosure absences and business changes, plus concerns about experience and stability. Vestand missed requirements including a $1 minimum price and timely quarterly and annual filings.

Original reporting
Published Jul 29, 2026, 1:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 29, 2026, 1:28 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Vestand, Formerly Yoshiharu, Delisted from Nasdaq — source image
Decision brief

The 30-second read

Med
01

Why it matters

Nasdaq’s delisting decision, tied to disclosure lapses and failure to meet minimum price and reporting requirements, increases liquidity and compliance risk and can reduce institutional participation.

02

Market read

Traders should reassess liquidity, spread, and downside risk after the exchange downgrade and the stated compliance failures.

03

What to watch

The article does not quantify the likelihood/timeline of reinstatement, nor does it detail any financing or restructuring plans that could materially change survival odds.

Relevance 6/10Novelty 6/10Timing: after-hours/next-session impact from July 27 Nasdaq delisting and July 28 filing rationale

Background

Vestand Inc., formerly Yoshiharu Ramen, went public in 2022 and began trading on the OTC Pink Limited Market the same day as the Nasdaq delisting.

Market effects

Adds to the microcap delisting risk narrative, potentially raising perceived compliance risk premia across similar OTC-to-Nasdaq issuers.

Primarily US microcap liquidity and exchange-structure impact.

Limited beyond US small-cap/OTC investor base.

Counterpoint

If Vestand can quickly cure reporting deficiencies and regain compliance, the OTC period could be a temporary dislocation rather than a permanent impairment.

Key entities

  • Nasdaq Hearings Panel

    Cited prolonged absence of public disclosure and reservations about experience and institutional stability for the delisting decision.

  • Vestand Inc.

    Ramen chain that pivoted in 2025 to real estate development and digital asset ventures; failed Nasdaq listing requirements and was delisted.

Related articles

$VSTDHighAI 9/10

Vestand Receives Nasdaq Staff Determination Notification Regarding Late 10-Q and 10-K Filings and Continued Listing Requirements

Vestand Inc. (NASDAQ: VSTD) said Nasdaq issued a May 19, 2026 staff delisting determination after the company failed to file Form 10-Qs for Sept. 30, 2025 and March 31, 2026 and Form 10-K for Dec. 31, 2025. Nasdaq initiated a delisting process, but it has no immediate effect. Vestand filed a May 22 hearing request to appeal and seek a stay while it prepares the delinquent reports.

$AONMedAI 9/10

Aon plc (AON): Other Events

Aon plc (AON) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On September 14, 2026, Aon North America, Inc., a Delaware corporation (“ANA”), Aon Global Holdings plc, a public limited company formed under the laws of England and Wales (“AGH” and, together with ANA, the “Issuers”), Aon plc, an Irish public limited com

$CICBMed

CION Investment Corp (CICB): Other Events

CION Investment Corp (CICB) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. On September 17, 2026, CĪON Investment Corporation (“CION”) entered into an Amended and Restated Limited Liability Company Agreement (the “LLC Agreement”) of Senior Loan Fund Partners, LLC (the “Joint Venture”), a newly formed Delaware limited liability c